Home > Cashflow Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Cashflow Statement

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹2.02 Cr₹57 Cr₹55 Cr₹44 Cr₹8.79 Cr
Adjustment ₹-1.14 Cr₹8.03 Cr₹1.18 Cr₹-0.59 Cr₹0.03 Cr
Changes In working Capital ₹11 Cr₹-47 Cr₹-16 Cr₹-41 Cr₹-22 Cr
Cash Flow after changes in Working Capital ₹12 Cr₹18 Cr₹40 Cr₹2.60 Cr₹-13 Cr
Cash Flow from Operating Activities ₹4.87 Cr₹6.08 Cr₹34 Cr₹0.00 Cr₹-14 Cr
Cash Flow from Investing Activities ₹-1.05 Cr₹-11 Cr₹-28 Cr₹-5.97 Cr₹-0.18 Cr
Cash Flow from Financing Activities ₹30 Cr₹26 Cr₹-0.16 Cr₹3.65 Cr₹18 Cr
Net Cash Inflow / Outflow ₹34 Cr₹21 Cr₹5.53 Cr₹-2.32 Cr₹3.88 Cr
Opening Cash & Cash Equivalents ₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr₹0.10 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr

Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹275.8 Cr -5.6% -6.8% -59.7% Stock Analytics
ADANI ENTERPRISES ₹283,732.0 Cr -3.3% -1.7% -22.8% Stock Analytics
REDINGTON ₹23,187.4 Cr -0.9% 5% 32.9% Stock Analytics
MMTC ₹10,423.5 Cr -2.6% 13.7% -6.3% Stock Analytics
HONASA CONSUMER ₹10,010.8 Cr -1.3% 13.1% -30.2% Stock Analytics
LLOYDS ENTERPRISES ₹8,982.5 Cr -2.9% 40.3% 114.6% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-5.6%

-6.8%

-59.7%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses